Ignite Creation Date:
2025-12-25 @ 2:17 AM
Ignite Modification Date:
2026-04-08 @ 11:08 AM
Study NCT ID:
NCT00262860
Status:
COMPLETED
Last Update Posted:
2016-05-09
First Post:
2005-12-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Bortezomib and Gemcitabine Hydrochloride in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
Sponsor:
University of Rochester
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CDR0000448635
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None